Ever Source Wealth Advisors, LLC Janux Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 140 shares of JANX stock, worth $3,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140
Previous 105
33.33%
Holding current value
$3,263
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JANX
# of Institutions
186Shares Held
55.9MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$261 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$104 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$68.1 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$58.9 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$54.6 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $971M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...